---
title: 'Use of artificial intelligence for liver diseases: A survey from the EASL
  congress 2024'
date: '2024-11-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39583096/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241125170918&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Artificial intelligence (AI) methods enable humans to analyse large amounts
  of data, which would otherwise not be feasibly quantifiable. This is especially
  true for unstructured visual and textual data, which can contain invaluable insights
  into disease. The hepatology research landscape is complex and has generated large
  amounts of data to be mined. Many open questions can potentially be addressed with
  existing data through AI methods. However, the field of AI is sometimes obscured
  by ...
disable_comments: true
---
Artificial intelligence (AI) methods enable humans to analyse large amounts of data, which would otherwise not be feasibly quantifiable. This is especially true for unstructured visual and textual data, which can contain invaluable insights into disease. The hepatology research landscape is complex and has generated large amounts of data to be mined. Many open questions can potentially be addressed with existing data through AI methods. However, the field of AI is sometimes obscured by ...